» Articles » PMID: 18403733

Critical Cap Thickness and Rupture in Symptomatic Carotid Plaques: the Oxford Plaque Study

Overview
Journal Stroke
Date 2008 Apr 12
PMID 18403733
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Advances in carotid plaque imaging could allow quantification of fibrous cap thickness in vivo. While a cap thickness <65 microm is the accepted definition of rupture-prone plaque in the coronary circulation, the threshold value for carotid plaques is unknown.

Methods: We made detailed histological assessments of 526 carotid plaques from consecutive patients undergoing endarterectomy for symptomatic carotid stenosis. The thickness of the fibrous cap at the thinnest and most representative part was measured.

Results: Cap thickness could be measured reliably in 428 (81%) plaques. In the ruptured plaques (n=257), the median representative cap thickness was 300 microm (IQR 200 to 500 microm) and the median minimum cap thickness was 150 microm (80 to 210 microm; mean=181 microm), which is much greater than the mean cap thickness of 23 microm at the point of rupture that has been reported for coronary plaques. For nonruptured plaques, the median cap thickness values were 500 microm (300 to 700 microm) and 250 microm (180 to 400 microm), respectively. The optimum cut-offs for discriminating between ruptured and nonruptured plaques were a minimum cap thickness <200 microm (OR 5.00, 3.26 to 7.65, P<0.001), a representative cap thickness <500 microm (OR 3.38, 2.25 to 5.08, P<0.001), or a combination of both (OR 5.11, 3.19 to 8.19, P<0.001). Minimum and representative cap thickness were only modestly correlated (r(2)=0.30) and were both independently associated with cap rupture.

Conclusions: Critical cap thickness is greater in carotid plaques than coronary plaques. Minimum and representative cap thicknesses were both independently associated with cap rupture. A combination of minimum cap thickness <200 microm and a representative cap thickness <500 microm identified ruptured plaques most reliably. Prospective imaging studies are required to establish whether these cut points predict clinical events in patients with asymptomatic carotid stenosis.

Citing Articles

An atypical atherogenic chemokine that promotes advanced atherosclerosis and hepatic lipogenesis.

El Bounkari O, Zan C, Yang B, Ebert S, Wagner J, Bugar E Nat Commun. 2025; 16(1):2297.

PMID: 40055309 PMC: 11889166. DOI: 10.1038/s41467-025-57540-z.


Manifestations of human atherosclerosis across vascular beds.

Jovin D, Sumpio B, Greif D JVS Vasc Insights. 2025; 2.

PMID: 39822712 PMC: 11737335. DOI: 10.1016/j.jvsvi.2024.100089.


Long Non-Coding RNA Function in Smooth Muscle Cell Plasticity and Atherosclerosis.

Maegdefessel L, Fasolo F Arterioscler Thromb Vasc Biol. 2024; 45(2):172-185.

PMID: 39633574 PMC: 11748911. DOI: 10.1161/ATVBAHA.124.320393.


Comparison of computer-aided quantitative measurement and physician visual assessment in the evaluation of intracranial atherosclerotic stenosis: a vessel wall magnetic resonance imaging study.

Du Y, Sun L, Wang Y, Li F, Hu T, Wu Y Quant Imaging Med Surg. 2024; 14(10):7459-7471.

PMID: 39429604 PMC: 11485378. DOI: 10.21037/qims-24-788.


F-NaF uptake on vascular PET imaging in symptomatic versus asymptomatic atherosclerotic disease: A meta-analysis.

Bhakta S, Chowdhury M, Tarkin J, Rudd J, Warburton E, Evans N Vasc Med. 2024; 30(1):10-19.

PMID: 39415512 PMC: 11804149. DOI: 10.1177/1358863X241287692.